Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico Implications for hepatitis A vaccination

• Published in: Human vaccines & immunotherapeutics Vol. 9; no. 2; pp. 375 - 381
• Main Authors: Lazcano-Ponce, Eduardo, Conde-Gonzalez, Carlos, Rojas, Rosalba, DeAntonio, Rodrigo, Romano-Mazzotti, Luis, Cervantes, Yolanda, Ortega-Barria, Eduardo
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.02.2013; Landes Bioscience
• Subjects: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Cost-Benefit Analysis; Cross-Sectional Studies; endemicity; Female; Hepatitis A - epidemiology; Hepatitis A - immunology; Hepatitis A - prevention & control; Hepatitis A Antibodies - blood; hepatitis A vaccine; Hepatitis A Vaccines - administration & dosage; Hepatitis A Vaccines - economics; hepatitis A virus; Hepatitis A Virus, Human - immunology; Humans; Immunoassay; Infant; Luminescent Measurements; Male; Mexico; Mexico - epidemiology; Middle Aged; Research Paper; Seroepidemiologic Studies; seroprevalence; Sex Factors; Socioeconomic Factors; Topography, Medical; Young Adult; Mexico; seroprevalence; Mexico; hepatitis A vaccine; endemicity; hepatitis A virus

Hepatitis A virus (HAV) remains a public health concern worldwide contributing to significant morbidity in developed and developing countries. This cross-sectional database study estimated the overall HAV seroprevalence and the seroprevalence by gender, age, region and socioeconomic status in Mexico...